Circular RNAs in acute myeloid leukemia

Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical problem. While...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Vijendra, Uddin, Mohammed Hafiz, Zonder, Jeffrey A., Azmi, Asfar S., Balasubramanian, Suresh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600814/
https://www.ncbi.nlm.nih.gov/pubmed/34794438
http://dx.doi.org/10.1186/s12943-021-01446-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600814/
https://www.ncbi.nlm.nih.gov/pubmed/34794438
http://dx.doi.org/10.1186/s12943-021-01446-z

Ejemplares similares